a year ago
TGTX
AnalystsMatthew KaplanMatthew Kaplan's Stock Forecasts
AnalystsMatthew Kaplan
Analyst Ranking
Top 21%
#993 out of 4873 analysts
Average Return
+11.71%
Win Rate
46%11 out of 24
Risk vs Reward
Poor
Good
Matthew Kaplan's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Tg Therapeutics IncTGTX | +176.31% | $16.42 | $45.37 | 2024-05-01 - 2025-05-01 | Strong Buy |
Tg Therapeutics IncTGTX | +173.91% | $13.99 | $38.32 | 2024-04-17 - 2025-04-17 | Strong Buy |
Reata Pharmaceuticals IncRETA | +64.10% | $100.90 | $165.58 | 2023-06-28 - 2023-07-31 | Strong Buy |
Liquidia CorpLQDA | +56.73% | $5.20 | $8.15 | 2022-07-21 - 2023-07-21 | Strong Buy |
Albireo Pharma IncALBO | +52.86% | $22.59 | $34.53 | 2017-02-15 - 2018-02-16 | Strong Buy |
Matthew Kaplan Analyst Color
Get additional color on Matthew Kaplan's coverage of popular stocks
Matthew Kaplan's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
United Therapeutics CorpUTHR | 4 | Strong Buy | $344.00 | +11.69% | Maintains | 6 months ago |
Urogen Pharma LtdURGN | 1 | Strong Buy | $53.50 | +401.41% | Maintains | a year ago |
Tg Therapeutics IncTGTX | 3 | Strong Buy | $40.00 | N/A | Maintains | a year ago |
Liquidia CorpLQDA | 2 | Strong Buy | $30.00 | N/A | Maintains | a year ago |
Ardelyx IncARDX | 3 | Strong Buy | $8.50 | N/A | Maintains | 2 years ago |
Reata Pharmaceuticals IncRETA | 3 | Hold | $172.50 | N/A | Downgrades | 2 years ago |
Avadel Pharmaceuticals PLCAVDL | 1 | Strong Buy | $16.00 | N/A | Maintains | 2 years ago |
Kiora Pharmaceuticals IncKPRX | 2 | Strong Buy | $1,071.00 | N/A | Reiterates | 2 years ago |
Beyond Air IncXAIR | 1 | Strong Buy | $23.00 | N/A | Maintains | 3 years ago |
Antares Pharma IncATRS | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Allena Pharmaceuticals IncALNAQ | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Onkure Therapeutics IncOKUR | 1 | Strong Buy | $450.00 | N/A | Initiates Coverage On | 3 years ago |
Tempest Therapeutics IncTPST | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Lipocine IncLPCN | 1 | Strong Buy | $51.00 | N/A | Upgrades | 4 years ago |
Cogent Biosciences IncCOGT | 1 | Strong Buy | $16.00 | N/A | Initiates Coverage On | 5 years ago |
Protara Therapeutics IncTARA | 1 | Strong Buy | $45.00 | N/A | Initiates Coverage On | 5 years ago |
Athenex IncATNXQ | 1 | Strong Buy | $540.00 | N/A | Initiates Coverage On | 7 years ago |
Albireo Pharma IncALBO | 1 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.